SecBot SecBot

CTEV

Claritev Corp
NYSE· Services-Business Services, NEC· Inc. DE· CIK 0001793229 Software & IT
$25.78 −1.03 (−3.86%)
Nov 16 4:00 PM ET · prev $26.82
Market cap
$459.1M
Small cap
Consensus
Buy
82% Buy or better · 11 analysts
Median target
$44.00
+71% · range $30.00–82.00
1 year
−32.4%
from $38.13 · Nov 17
30 days
+16.6%
from $22.12
52-week range
$13.47–54.87
−53% from high · low Feb 27
Avg volume 20D
310.0K
Nov 10 spike 933.1K
Short interest
770.0K
≈4.5% of shares · −16.1%
Days to cover
2.9
at average volume
Insider net
+$7.5M
7 buyers · 4 sellers · since Mar 1
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
21
analyzed by SecBot
SecBot read MIXED 13 reports · 90 days
Balance 1 bearish · 2 bullish · 1 mixed · 9 neutral oldest → newest, height = score
Avg score ·High conf. 10/13

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    7 insiders bought $10.4M at an average $23.84. 4 insiders sold $2.9M. Price is 8% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 18 added (0 new), 8 trimmed or exited.

  • AnalystsBULLISH

    9 of 11 rate it Buy or better. Every target is above the price.

  • Short sellersCOVERING

    Short interest −16.1% to 770.0K shares. 2.9 days to cover, ≈4.5% of shares.

  • TrendRANGE

    1% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CHARLES SCHWAB INVESTMENT MANAGEMENT INCTRIM167,006$5.7M
Allianz Asset Management GmbHADD91,773$3.1M
Point72 Asset Management, L.P.TRIM39,000$1.3M
GOLDMAN SACHS GROUP INCADD27,024$921.8K
Bank of New York Mellon CorpADD26,750$912.4K
MORGAN STANLEYNEAR_EXIT21,460$732.0K
MARSHALL WACE, LLPNEAR_EXIT13,533$461.6K
BARCLAYS PLCNEAR_EXIT11,558$394.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 82% rate it Buy or better
Strong Buy3Buy6Hold2Sell0Strong Sell0
12-month targets · 5 analysts

Price is below the lowest target. Median implies +71%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Aug 21, 2026Barclays
MAINTAIN
MAINTAINOverweight
Aug 12, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Aug 10, 2026Citigroup
MAINTAIN
MAINTAINBuy
Aug 10, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Jul 21, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
May 29, 2026Canaccord Genuity
INITIATE
INITIATEBuy

Insider ledger

Form 4
$10.4M
bought · 7 insiders
$2.9M
sold · 4 insiders
+8.1%
vs their $23.84 cost
DateInsiderTypeValue
Nov 12, 2026
Klein Michael Stuart
Director
Nov 12, 2026
SELL$543.3K
Nov 11, 2026
Dalton Travis
Pres., CEO & Executive Chair
Nov 11, 2026
BUY$149.9K
Nov 11, 2026
Klein Michael Stuart
Director
Nov 11, 2026
SELL$1.1M
Nov 10, 2026
ARES MANAGEMENT LLC
10%+ Owner
Nov 10, 2026
BUY$1.7M
Nov 10, 2026
ARES MANAGEMENT LLC
10%+ Owner
Nov 10, 2026
BUY$1.7M
Nov 10, 2026
Klein Michael Stuart
Director
Nov 10, 2026
SELL$130.6K
Nov 9, 2026
ARES MANAGEMENT LLC
10%+ Owner
Nov 9, 2026
BUY$1.2M
Nov 9, 2026
ARES MANAGEMENT LLC
10%+ Owner
Nov 9, 2026
BUY$1.2M

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q$1.78$1.99–$1.78No data$264.9M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

24 lobbying filings and 2 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
770,035
shares short
-16.1%
vs prior settlement
2.9
days to cover
≈4.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
A mixed insider cluster at Claritev Corp shows a 10% owner (Ares Management) buying $1.71M and the CEO buying $150K…
CLUSTER · Impact 4/10
Nov 12, 2026 SEC
Ares Management LLC, a 10% owner, purchased $1.71M of CTEV stock in open-market buys while Director Michael Klein sold…
CLUSTER · Impact 4/10
Nov 12, 2026 Insider
Klein Michael Stuart sold 20,067 shares
Director @ $27.07 ($543.3K)
Nov 11, 2026 Insider
Dalton Travis bought 5,110 shares
Pres., CEO & Executive Chair @ $29.34 ($149.9K)
Nov 11, 2026 Insider
Klein Michael Stuart sold 40,000 shares
Director @ $28.60 ($1.1M)
Nov 9, 2026 Earnings
Claritev Corporation Reports Third Quarter 2026 Results
MCLEAN, Va., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (N
Jun 30, 2026 Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT · TRIM
167,006 shares ($5.7M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 9, 2026
Earnings
Claritev Corporation Reports Third Quarter 2026 Results
MCLEAN, Va., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data and insights…
Nov 9, 2026
Earnings result
CTEV Q3 2026 Earnings: EPS $-3.64 (+1.6% vs est)
Nov 5, 2026
Press release
Claritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
MCLEAN, Va., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights…
Oct 29, 2026
Press release
Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement Intelligence
Claritev launches AI-enabled Transparency-Based Pricing, turning public healthcare pricing data into actionable reimbursement intelligence.
Oct 15, 2026
Press release
Claritev Appoints Jennifer Main to its Board of Directors
Board gains deep public sector healthcare and financial leadership expertise to support Claritev's growth strategy...

SecBot reports

21 filings · 7 bullish · 2 bearish · 2 mixed · 10 neutral
All CTEV filing & press-release reports (21)